First, owing to the limited number of CLL patients in Taiwan, we could not correlate the expression level of CD22 (transcript or protein) on B cells with the prognosis of Taiwanese CLL patients. This evidence concerns the gene CD22 and B-cell chronic lymphocytic leukemia.